Last week was a rough one for investors, as ten-year treasury yields pushed to seven-year highs and President Trump sounded skeptical about the U.S/China trade war coming to an...
Keep Reading →
May 21 - Insider Trading, News
In a major surprise for Dermira Inc. and Wall Street alike, Dermira’s acne drug failed to meet the co-primary endpoints of two important, late-stage clinical trials.
Keep Reading →
March 5 - Market Movers, News
Bill Miller is a legendary investor whose fund that he managed at Legg Mason managed to beat the S&P 500 for 15 straight years through 2015.
Keep Reading →
December 18 - Hedge Funds, News
"Stocks rose on Wall Street on Thursday, capping a wave of declines in major world equity markets triggered by uncertainty over U.S.
Keep Reading →
May 18 - Commodities, Futures/Forex, Gold, Market Movers, News, Tech
"The S&P 500 and the Nasdaq Composite hit fresh intraday records on Monday as a jump in oil prices to a two-week high lifted Wall Street sentiment.
Keep Reading →
May 15 - Commodities, Futures/Forex, Gold, Market Movers, News, Tech
"U.S. and European stocks fell on Thursday, along with the U.S. dollar, while U.S.
Keep Reading →
May 11 - Commodities, Futures/Forex, Gold, Market Movers, News, Tech
"U.S. stocks retreated on Tuesday as a spate of tepid corporate earnings weighed on the broader market.
Keep Reading →
April 18 - Commodities, Gold, Market Movers, News, Tech
"U.S. stocks traded firmly higher Wednesday, with the Nasdaq Composite setting an intraday record, after a strong reading on private-sector hiring in March.
Keep Reading →
April 5 - Commodities, Gold, Market Movers, News, Tech
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) has fallen 4.67%, or $0.48 per share, to below the psychologically important $10 level on Wednesday after The Australian reported...
Keep Reading →
April 5 - Market Movers, News
“Wall Street stocks on Monday were aiming to start the second quarter with tepid gains.
Keep Reading →
April 3 - Commodities, Gold, Market Movers, News, Tech
Thirteen years ago Eric Mindich set an industry record when he raised $3 billion for his new hedge fund Eton Park.
Keep Reading →
March 23 - Hedge Funds
(Reuters Breakingviews) - The last chapter for Sears looks to be at hand. The troubled U.S.
Keep Reading →
March 22 - Hedge Funds
Among the stocks that traders are also watching include several major companies, Apple Inc. (NASDAQ:AAPL), Caterpillar Inc.
Keep Reading →
March 17 - News
Crude futures are in the green today as investors look forward to today's upcoming EIA data dump.
Keep Reading →
March 15 - News
Shares of Valeant Pharmaceuticals dropped Tuesday after news surfaced late Monday that billionaire hedge fund manager Bill Ackman sold his remaining stock in the company.
Keep Reading →
March 14 - Hedge Funds
Pershing Square Capital Management, managed by Bill Ackman, sold its entire stake in Valeant Pharmaceuticals Intl Inc (NYSE:VRX) on Monday.
Keep Reading →
March 14 - Hedge Funds, News, Stock Analysis
Although the FOMC meets on Tuesday and Wednesday, the market hasn't been as volatile as it used to be.
Keep Reading →
March 14 - News
Peltz is that rare breed of insurgent known as "operational activists" because his track record as an operator sets him apart from "financial activists," investors from a hedge...
Keep Reading →
March 13 - Hedge Funds
Amid the political uncertainty in Europe and expectations of a stronger U.S. economy, David Tepper's approach to go long on European equities and short on U.S.
Keep Reading →
March 9 - Hedge Funds
Bill Ackman's Pershing Square is well-known for holding a concentrated equity portfolio with a few, but rather large, positions.
Keep Reading →
February 16 - Hedge Funds, News
Shares of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) jumped more than 14% in pre-market trading yesterday, after the Canadian drug maker announced its long-awaited asset sale...
Keep Reading →
January 12 - News, Stock Analysis
Yes, you read the title right there are at least 12 health benefits of medical marijuana according to publicly traded weed companies.
Keep Reading →
January 12 - Lists, News
The secret to getting the most out the hedge fund industry for profits is to filter out the noise and focus on selected sides of the smart money’s portfolios.
Keep Reading →
December 9 - Hedge Fund Analysis, Hedge Funds, News
William Ackman sliced in half his losses for the year after a strong November at Pershing Square Capital Management LP. Mr.
Keep Reading →
December 2 - Hedge Funds
Pershing Square Capital Management is a New York-based hedge fund founded by billionaire investor Bill Ackman.
Keep Reading →
December 2 - Hedge Fund Analysis, Hedge Funds, News
Buyout talks between Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Takeda Pharmaceutical Co Ltd (ADR) (OTCMKTS:TKPYY) that would have resulted in the sale of Salix Pharmaceuticals...
Keep Reading →
December 1 - News, Stock Analysis
Chou Associates Management Inc. aims to provide long term growth of capital. The fund mainly invests in the US securities and has fairly diversified portfolio.
Keep Reading →
December 1 - Hedge Funds, News
LMM Investments is a Baltimore-based hedge fund founded by Bill Miller, the famous value investor who is known for beating the S&P 500 15 years in a row.
Keep Reading →
November 23 - Hedge Fund Analysis, Hedge Funds, News
In mid-day action, WTI futures are trading above $45 per barrel as OPEC's November 30 meeting to iron out the details of their proposed production cut nears.
Keep Reading →
November 15 - News
Pershing Square Capital Management is a New York-based hedge fund managed by billionaire investor Bill Ackman.
Keep Reading →
November 15 - Hedge Fund Analysis, Hedge Funds, News
Just like Main Street, this election season also saw Wall Street divided into two factions based on who they supported.
Keep Reading →
November 14 - Hedge Funds, News
Bill Ackman of Pershing Square recently did an interview with Andrew Ross Sorkin at the DealBook conference in New York and Insider Monkey was there to cover it.
Keep Reading →
November 11 - Activism, Hedge Funds, News
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) had an incredibly rough day on the market yesterday, and for good reason.
Keep Reading →
November 9 - News, Stock Analysis
Hedge fund manager David Einhorn opted against shifting his portfolio to prepare for market volatility tied to the results of U.S. elections.
Keep Reading →
November 8 - Hedge Funds
Canada’s Valeant Pharmaceuticals Intl Inc (NYSE:VRX) is contemplating selling some of its assets the most notable one being it’s Salix gastrointestinal unit.
Keep Reading →
November 3 - News, Stock Analysis
Crude futures are in the red after the API reported a massive 9.3 million-barrel build on Tuesday.
Keep Reading →
November 2 - News
Emerson Electric Co. (NYSE:EMR): reported Q4 EPS of $0.96 which beat by $0.06. Revenues were $5.5 billion which was down 5.3% year over year missing estimates by $10 million.
Keep Reading →
November 1 - Earnings Report, News
With crude futures up and the latest batch of earnings reports improving sentiment, all three indexes have opened moderately in the green. Among the stocks that traders are watching...
Keep Reading →
November 1 - Market Movers, News
Some renowned investors have recently talked about Apple Inc. (NASDAQ:AAPL) Valeant Pharmaceuticals Intl Inc (NYSE:VRX), Alphabet Inc (NASDAQ:GOOGL) St. Jude Medical, Inc.
Keep Reading →
October 31 - Hedge Fund Investor Letters, Hedge Funds, News, Tech
Activist investor Paul Singer doesn’t think conflict is brewing with Samsung Electronics Co., one of the latest targets in his quest to push for changes that benefit shareholders...
Keep Reading →
October 25 - Hedge Funds
Although several major companies have recently reported earnings, shares of five other companies, Clayton Williams Energy, Inc. (NYSE:CWEI), Netflix, Inc.
Keep Reading →
October 25 - News
While the second trading week of the fourth quarter is officially over, several major stocks are trending over the weekend, including Twitter Inc (NYSE:TWTR), salesforce.com, ...
Keep Reading →
October 15 - News, Tech
In this article we'll take a look at why VeriFone Systems Inc (NYSE:PAY), Dynavax Technologies Corporation (NASDAQ:DVAX), Gilead Sciences, Inc.
Keep Reading →
September 5 - Market Movers, News
Billionaire investor William Ackman's portfolios climbed nearly 6 percent in August, boosted by strong gains at drug company Valeant Pharmaceuticals International Inc where changes...
Keep Reading →
September 2 - Hedge Funds
AMAG Pharmaceuticals, Inc.
Keep Reading →
August 30 - Hedge Funds, News, Stock Analysis
Billionaire hedge fund boss Bill Ackman told CNBC on Friday the past 12 months were the "worst period of performance" of his investment career, and the implosion of Valeant Pharmaceuticals...
Keep Reading →
August 26 - Hedge Funds
Among the stocks in the spotlight are Mylan NV (NASDAQ:MYL), Transocean LTD (NYSE:RIG), Netflix, Inc. (NASDAQ:NFLX), Seadrill Ltd (NYSE:SDRL), and Tiffany & Co. (NYSE:TIF).
Keep Reading →
August 25 - Earnings Report, Market Movers, News
Raging Capital Management is a New Jersey-based hedge fund founded in 2006 by William Martin. The fund manages a U.S.
Keep Reading →
August 22 - Hedge Fund Analysis, Hedge Funds, News
